» Articles » PMID: 11230429

Phenotypic Methods for Determining Genomovar Status of the Burkholderia Cepacia Complex

Overview
Specialty Microbiology
Date 2001 Mar 7
PMID 11230429
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Recent taxonomic advances have demonstrated that Burkholderia cepacia is a cluster of at least seven closely related genomic species (or genomovars) collectively referred to as the B. cepacia complex, all of which may cause infections among cystic fibrosis patients and other vulnerable individuals. Thus, it is important for clinical microbiologists to be able to differentiate genomovars. Prior to this study, 361 B. cepacia complex isolates and 51 isolates easily confused with B. cepacia complex previously had been identified using a polyphasic approach, and in this study, a comparison of phenotypic and biochemical tests was carried out. It was determined that Burkholderia multivorans and Burkholderia stabilis could reliably be separated from other members of the B. cepacia complex by phenotypic methods. A combination of phenotypic and molecular tests such as recA PCR and 16S rRNA RFLP are recommended for differentiation among the genomovars of the B. cepacia complex. A biochemical reaction scheme for the identification of B. gladioli, Pandoraea species, and Ralstonia pickettii and the differentiation of these species from the B. cepacia complex is also presented.

Citing Articles

Convergence of Hypervirulence and Multidrug-Resistance in Complex Isolates from Patients with COVID-19.

Du M, Chi C, Xiong L, Rong J, Yi M, Zhao Q Infect Drug Resist. 2025; 17:5855-5866.

PMID: 39741887 PMC: 11687121. DOI: 10.2147/IDR.S495676.


Identification of Burkholderia cepacia Complex: Comparing Conventional, Automated, and Molecular Methods in a Tertiary Care Center.

Periaiah P, Antony T, Samuel S Cureus. 2024; 16(10):e70847.

PMID: 39493122 PMC: 11531786. DOI: 10.7759/cureus.70847.


Novel application of metagenomics for the strain-level detection of bacterial contaminants within non-sterile industrial products - a retrospective, real-time analysis.

Cunningham-Oakes E, Pointon T, Murphy B, Campbell-Lee S, Connor T, Mahenthiralingam E Microb Genom. 2023; 8(11).

PMID: 36748522 PMC: 9836090. DOI: 10.1099/mgen.0.000884.


An Overview of Metabolic Activity, Beneficial and Pathogenic Aspects of Spp.

Elshafie H, Camele I Metabolites. 2021; 11(5).

PMID: 34067834 PMC: 8156019. DOI: 10.3390/metabo11050321.


A Phylogeny-Informed Proteomics Approach for Species Identification within the Burkholderia cepacia Complex.

Wang H, Cisse O, Bolig T, Drake S, Chen Y, Strich J J Clin Microbiol. 2020; 58(11).

PMID: 32878952 PMC: 7587091. DOI: 10.1128/JCM.01741-20.


References
1.
Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R . Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997; 47(4):1188-200. DOI: 10.1099/00207713-47-4-1188. View

2.
Segonds C, Bingen E, Couetdic G, Mathy S, Brahimi N, Marty N . Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol. 1997; 35(8):2055-60. PMC: 229902. DOI: 10.1128/jcm.35.8.2055-2060.1997. View

3.
Bauernfeind A, Schneider I, Jungwirth R, Roller C . Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol. 1999; 37(5):1335-9. PMC: 84768. DOI: 10.1128/JCM.37.5.1335-1339.1999. View

4.
Vandamme P, Goris J, Coenye T, Hoste B, Janssens D, Kersters K . Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int J Syst Bacteriol. 1999; 49 Pt 2:663-9. DOI: 10.1099/00207713-49-2-663. View

5.
van Pelt C, Verduin C, Goessens W, Vos M, Tummler B, Segonds C . Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol. 1999; 37(7):2158-64. PMC: 85108. DOI: 10.1128/JCM.37.7.2158-2164.1999. View